NAD Phyto offering anti-aging and immune system boosting Solution to fight the Coronavirus

An article based on research done By Harvard Medical school was published by;

MailOnline - news, sport, celebrity, science and health stories

on 3 May 2020. The article had been written by  VANESSA CHALMERS HEALTH REPORTER FOR MAILONLINE.

The headline:

"Elderly coronavirus patients should be given anti-ageing drugs to make their immune systems 'younger' so they can fight the virus faster, scientists claim

  • As a person ages, their immune system becomes suppressed and slower
  • It gives the killer coronavirus time to replicate and cause serious disease  
  • But Harvard scientists say this could be fixed by with NAD boosters
  • The drug would boost levels of NAD+, which naturally decline as we age 
  • The relatively new supplement has not been studied extensively in humans 
  • But the scientists claim they could alleviate COVID symptoms and prevent death
  • Here’s how to help people impacted by Covid-19"

The above is a direct extract from the Mail Online article which can be found here: https://www.dailymail.co.uk/news/article-8281975/Elderly-coronavirus-patients-given-anti-ageing-drugs-make-immune-systems-younger.html

A Harvard Medical School article "Rewinding the Clock"

References for this article on NAD plus Phyto rewinding the clock:

The Mail Online :

"Elderly coronavirus patients should be given anti-ageing drugs to make their immune systems 'younger' so they can fight the virus faster, scientists claim"

by Vanessa Chalmers Health reporter for the Mailonline. - 3 May 2020

Link : https://www.dailymail.co.uk/news/article-8281975/Elderly-coronavirus-patients-given-anti-ageing-drugs-make-immune-systems-younger.html

____________________________________________________

Harvard Medical School - Rewinding the Clock - Coronavirus - News and Research -  

Link: https://hms.harvard.edu/news/rewinding-clock

Categories: Uncategorised

0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

0